BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37087424)

  • 1. Cycling in primary progressive multiple sclerosis (CYPRO): study protocol for a randomized controlled superiority trial evaluating the effects of high-intensity interval training in persons with primary progressive multiple sclerosis.
    Kupjetz M; Joisten N; Rademacher A; Gonzenbach R; Bansi J; Zimmer P
    BMC Neurol; 2023 Apr; 23(1):162. PubMed ID: 37087424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
    Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
    BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
    Joisten N; Rademacher A; Bloch W; Schenk A; Oberste M; Dalgas U; Langdon D; Caminada D; Purde MT; Gonzenbach R; Kool J; Zimmer P; Bansi J
    BMC Neurol; 2019 Mar; 19(1):37. PubMed ID: 30849952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inpatient energy management education and high-intensity interval training on health-related quality of life in persons with multiple sclerosis: A randomized controlled superiority trial with six-month follow-up.
    Patt N; Kupjetz M; Kool J; Hersche R; Oberste M; Joisten N; Gonzenbach R; Nigg CR; Zimmer P; Bansi J
    Mult Scler Relat Disord; 2023 Oct; 78():104929. PubMed ID: 37579643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aerobic capacity - fatigue relationship in persons with Multiple Sclerosis is not reproducible in a pooled analysis of two randomized controlled trials.
    Wolf F; Rademacher A; Joisten N; Proschinger S; Schlagheck ML; Bloch W; Gonzenbach R; Kool J; Bansi J; Zimmer P
    Mult Scler Relat Disord; 2022 Feb; 58():103476. PubMed ID: 35065407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial.
    Hubbard EA; Motl RW; Elmer DJ
    Trials; 2020 Nov; 21(1):972. PubMed ID: 33239079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.
    Straudi S; Manfredini F; Lamberti N; Zamboni P; Bernardi F; Marchetti G; Pinton P; Bonora M; Secchiero P; Tisato V; Volpato S; Basaglia N
    Trials; 2017 Feb; 18(1):88. PubMed ID: 28241776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of High-Intensity Interval Training vs Moderate-Intensity Continuous Training in Patients With Fibromyalgia: A Pilot Randomized Controlled Trial.
    Atan T; Karavelioğlu Y
    Arch Phys Med Rehabil; 2020 Nov; 101(11):1865-1876. PubMed ID: 32585169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability.
    Silveira SL; Motl RW; Elmer DJ; Botkin T; Ontiveros T; Williams S; Hubbard EA
    Mult Scler Relat Disord; 2024 Jul; 87():105695. PubMed ID: 38820697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.
    Gravesteijn AS; Beckerman H; de Jong BA; Hulst HE; de Groot V
    BMC Neurol; 2020 May; 20(1):177. PubMed ID: 32393193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol, and practical challenges, for a randomised controlled trial comparing the impact of high intensity interval training against standard care before major abdominal surgery: study protocol for a randomised controlled trial.
    Woodfield J; Zacharias M; Wilson G; Munro F; Thomas K; Gray A; Baldi J
    Trials; 2018 Jun; 19(1):331. PubMed ID: 29941028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial.
    McGregor G; Powell R; Begg B; Birkett ST; Nichols S; Ennis S; McGuire S; Prosser J; Fiassam O; Hee SW; Hamborg T; Banerjee P; Hartfiel N; Charles JM; Edwards RT; Drane A; Ali D; Osman F; He H; Lachlan T; Haykowsky MJ; Ingle L; Shave R
    Eur J Prev Cardiol; 2023 Jul; 30(9):745-755. PubMed ID: 36753063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis.
    Joisten N; Rademacher A; Warnke C; Proschinger S; Schenk A; Walzik D; Knoop A; Thevis M; Steffen F; Bittner S; Gonzenbach R; Kool J; Bloch W; Bansi J; Zimmer P
    Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33782190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-duration aerobic high-intensity intervals versus moderate exercise training intensity in patients with peripheral artery disease: study protocol for a randomised controlled trial (the Angiof-HIIT Study).
    Lanzi S; Pousaz A; Fresa M; Besson C; Desgraz B; Gremeaux-Bader V; Mazzolai L
    BMJ Open; 2024 Apr; 14(4):e081883. PubMed ID: 38631833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.
    MacDonald G; Sitlinger A; Deal MA; Hanson ED; Ferraro S; Pieper CF; Weinberg JB; Brander DM; Bartlett DB
    Sci Rep; 2021 Nov; 11(1):23137. PubMed ID: 34848750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial.
    Dowman LM; May AK; Hill CJ; Bondarenko J; Spencer L; Morris NR; Alison JA; Walsh J; Goh NSL; Corte T; Glaspole I; Chambers DC; McDonald CF; Holland AE
    BMC Pulm Med; 2021 Nov; 21(1):361. PubMed ID: 34758808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-intensity training on peak oxygen uptake and muscular strength after lung transplantation: A randomized controlled trial.
    Ulvestad M; Durheim MT; Kongerud JS; Lund MB; Edvardsen E
    J Heart Lung Transplant; 2020 Sep; 39(9):859-867. PubMed ID: 32674956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of high-intensity, low-volume interval training compared to continuous aerobic training on insulin resistance, skeletal muscle structure and function in adults with metabolic syndrome: study protocol for a randomized controlled clinical trial (Intraining-MET).
    Gallo-Villegas J; Aristizabal JC; Estrada M; Valbuena LH; Narvaez-Sanchez R; Osorio J; Aguirre-Acevedo DC; Calderón JC
    Trials; 2018 Feb; 19(1):144. PubMed ID: 29482601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-intensity interval training on trajectories of gas-exchange measures and blood lactate concentrations during cardiopulmonary exercise tests in cardiac rehabilitation-A randomized controlled trial.
    Heber S; Gleiss A; Kuzdas-Sallaberger M; Hausharter M; Matousek M; Ocenasek H; Fischer B; Volf I; Pokan R
    Scand J Med Sci Sports; 2023 Aug; 33(8):1345-1359. PubMed ID: 37114323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.